Neuphoria Therapeutics, Inc. (NEUP)
4.715
-0.18
(-3.58%)
USD |
NASDAQ |
Jun 03, 16:00
4.715
0.00 (0.00%)
After-Hours: 19:59
Neuphoria Therapeutics EPS Diluted (Quarterly) : -0.0933 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Imunon, Inc. | -0.8449 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5051M |
| Total Expenses (Quarterly) | 0.5051M |
| Enterprise Value | 6.955M |
| Earnings Yield | 26.99% |
| Operating Earnings Yield | 14.21% |
| Normalized Earnings Yield | 49.66 |